This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Abstract Details
Activity Number:
|
62
|
Type:
|
Topic Contributed
|
Date/Time:
|
Sunday, August 1, 2010 : 4:00 PM to 5:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #307325 |
Title:
|
A Novel Bayesian Approach to Assessing the Risk of QT Prolongation
|
Author(s):
|
Suraj Anand*+ and Sujit Kumar Ghosh
|
Companies:
|
Novartis Pharmaceuticals Corporation and North Carolina State University
|
Address:
|
, , ,
|
Keywords:
|
TQT study ;
ICH E14 ;
Bayesian approach ;
mean QTc
|
Abstract:
|
The standard way of analyzing a TQT study is to construct a 90% two-sided confidence interval (CI), for the difference in baseline-corrected mean QTc between drug and placebo at each time point, and to conclude non-inferiority if the upper limit for each CI is less than 10 ms. The intent of the ICH E14 guidelines is to establish that the mean effect of the drug is less than 5 ms and the standard approach may not be well suited to achieve this goal. We propose a Bayesian approach to address this problem, keeping in line with the intent of the ICH E14 guidelines, by directly calculating the probability that the mean effect of the drug is no larger than 5 ms, thereby, providing a direct measure of evidence of whether the drug prolongs mean QTc beyond 5 ms. We assess the performance of our proposed approach using simulated data, discuss its advantages, and illustrate it using a real dataset.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2010 program
|
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.